It is one of the first development pre-clinical tests one does when moving a drug to human testing - ADME. I find it quite preposterous that you'd assume your new optimised lead will follow the same path as earlier compounds. You'd be hard pressed to find any company in the pharmaceutical sphere that would make those sorts of assumptions.
1AD Price at posting:
9.9¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)